Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−0.0758EUR
−2.12 MEUR
1.26 MEUR
About GENETIC ANALYSIS NK -,60
Sector
Industry
CEO
Ronny Hermansen
Website
Headquarters
Oslo
Founded
2008
ISIN
NO0010692130
FIGI
BBG0136X5Q37
Genetic Analysis AS develops in-vitro diagnostics tests in diseases where microbiota is involved. It is a molecular diagnostic company that provides gut microbiota analysis for testing bacterial imbalance in bowel syndrome and inflammatory bowel disease patients. The company's service products include GA-map dysbiosis test and COVID-19 fecal test and lab products include The GA-map dysbiosis test reagent kit and The COVID fecal test reagent kit. Genetic Analysis was founded in 2008 and is headquartered in Oslo, Norway.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange GENETIC ANALYSIS NK -,60 stocks are traded under the ticker 8V8.
GENETIC ANALYSIS NK -,60 is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
GENETIC ANALYSIS NK -,60 revenue for the last quarter amounts to 315.68 K EUR despite the estimated figure of 469.25 K EUR. In the next quarter revenue is expected to reach 229.77 K EUR.
Yes, you can track GENETIC ANALYSIS NK -,60 financials in yearly and quarterly reports right on TradingView.
8V8 net income for the last quarter is −593.28 K EUR, while the quarter before that showed −382.04 K EUR of net income which accounts for −55.29% change. Track more GENETIC ANALYSIS NK -,60 financial stats to get the full picture.
No, 8V8 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 8V8 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENETIC ANALYSIS NK -,60 stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENETIC ANALYSIS NK -,60 EBITDA is −2.43 M EUR, and current EBITDA margin is −217.41%. See more stats in GENETIC ANALYSIS NK -,60 financial statements.